Ample research findings in recent decades have shown that DDX5 could form a complex with β-catenin protein, which stimulated β-catenin transcriptional capacity and thus triggered the transcription of downstream target genes in human cancers [20, 42–44]. The gene discussed is DDX5; the disease is cancer.